Delivery Order SPE2DB22D1106-SPE2DB25FEZZ7
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,640.14 firm fixed price delivery order is for the pharmaceutical product ANGELIQ 0.5 MG-1 MG TABLET 28S. The contract has a completion date of February 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,928.48, is for the delivery of ANGELIQ 0.25 MG-0.5 MG tablets. This is a firm fixed-price delivery order contract with a completion date of December 24, 2024. The contract was awarded on December 23, 2022 and does not have a set-aside designation, indicating open competition. Amerisourcebergen...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $139,449.98 from the Defense Logistics Agency's Medical Supply Chain on July 28, 2025. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and was competitively awarded without set-aside designation. This delivery order represents a child contract action under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $11,523.65 to AmerisourceBergen Drug Corp on July 18, 2025, with an ultimate completion date of the same day. This firm fixed-price delivery order, issued without set-aside designation, represents a small-value pharmaceutical procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,068.48 to AmerisourceBergen Drug Corp on July 23, 2025, with a completion date of July 24, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle. The vendor, headquartered in Conshohocken, Pennsylvania, will perform work at its corporate office location and supply pharmaceutical and...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,183.36 by the Defense Logistics Agency's Medical Supply Chain on July 22, 2025, with a completion date of July 23, 2025. This non-set-aside contract represents a firm fixed price delivery order issued against AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of performance is AmerisourceBergen's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,684.19 to AmerisourceBergen Drug Corp on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded transaction for pharmaceutical products and medical supplies. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $1,590.98 to AmerisourceBergen Drug Corp on July 28, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order, issued under a non-set-aside competitive procurement, calls for pharmaceutical and medical supply deliveries to support federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- This delivery order, awarded July 21, 2025, represents a $4,038.72 firm fixed-price contract issued to AmerisourceBergen Drug Corp by the Defense Logistics Agency's Medical Supply Chain division. The contract, which is not set-aside and was competitively awarded, is a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The order is scheduled for ultimate completion on July 22, 2025,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order valued at $31,060.98 from the Defense Logistics Agency's Medical Supply Chain on July 28, 2025. This firm fixed-price contract, which is a child order under a larger indefinite delivery contract, has an ultimate completion date of July 29, 2025 and involves pharmaceutical and medical supply deliveries to support federal healthcare...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEZZ7Delivery Order
The Defense Logistics Agency awarded a $1,141.53 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Angeliq 0.25 mg-0.5 mg tablets (28-count units). This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, represents a non-set-aside, competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. The IDC supports military healthcare programs globally by enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. As a major pharmaceutical distributor and federal healthcare vendor, AmerisourceBergen has demonstrated substantial capability in meeting DLA procurement requirements through multiple delivery orders across diverse therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/28/25 |